<VariationArchive RecordType="classified" VariationID="183148" VariationName="NM_152268.4(PARS2):c.1130dup (p.Pro377_Lys378insTer)" VariationType="Duplication" Accession="VCV000183148" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-11-28" MostRecentSubmission="2020-11-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="181284" VariationID="183148">
      <GeneList>
        <Gene Symbol="PARS2" FullName="prolyl-tRNA synthetase 2, mitochondrial" GeneID="25973" HGNC_ID="HGNC:30563" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p32.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="54756898" stop="54764523" display_start="54756898" display_stop="54764523" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="55222570" stop="55230225" display_start="55222570" display_stop="55230225" Strand="-" />
          </Location>
          <OMIM>612036</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_152268.4(PARS2):c.1130dup (p.Pro377_Lys378insTer)</Name>
      <CanonicalSPDI>NC_000001.11:54758031:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p32.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="54758031" stop="54758032" display_start="54758031" display_stop="54758032" variantLength="1" positionVCF="54758031" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="55223704" stop="55223705" display_start="55223704" display_stop="55223705" variantLength="1" positionVCF="55223704" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.55223710dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.55223710dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.54758037dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.54758037dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042048.1" sequenceAccession="NG_042048" sequenceVersion="1" change="g.11522dup">
            <Expression>NG_042048.1:g.11522dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152268.4" sequenceAccession="NM_152268" sequenceVersion="4" change="c.1130dup" MANESelect="true">
            <Expression>NM_152268.4:c.1130dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_689481.2" sequenceAccession="NP_689481" sequenceVersion="2" change="p.Pro377_Lys378insTer">
            <Expression>NP_689481.2:p.Pro377_Lys378insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA235488" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="612036.0001" DB="OMIM" />
        <XRef Type="rs" ID="730882152" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_152268.4(PARS2):c.1130dup (p.Pro377_Lys378insTer) AND Developmental and epileptic encephalopathy, 75" Accession="RCV000162032" Version="7">
        <ClassifiedConditionList TraitSetID="47389">
          <ClassifiedCondition DB="MedGen" ID="C5193099">Developmental and epileptic encephalopathy, 75</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2015-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-11-28" MostRecentSubmission="2020-11-28">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22237560</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25629079</ID>
        </Citation>
        <DescriptionHistory Dated="2019-05-27">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="47389" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41776" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75</ElementValue>
                <XRef Type="MIM" ID="618437" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 75</ElementValue>
                <XRef ID="MONDO:0032752" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EIEE75</ElementValue>
                <XRef Type="MIM" ID="618437" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DEE75</ElementValue>
                <XRef Type="MIM" ID="618437" DB="OMIM" />
              </Symbol>
              <XRef ID="C5193099" DB="MedGen" />
              <XRef ID="MONDO:0032752" DB="MONDO" />
              <XRef Type="MIM" ID="618437" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="382049" SubmissionDate="2020-11-25" DateLastUpdated="2020-11-28" DateCreated="2015-03-03">
        <ClinVarSubmissionID localKey="612036.0001_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75" title="PARS2, 1-BP DUP, 1130C_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75" />
        <ClinVarAccession Accession="SCV000211959" DateUpdated="2020-11-28" DateCreated="2015-03-03" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Swedish boy with developmental and epileptic encephalopathy-75 (DEE75; 618437), reported as patient 15 in Sofou et al. (2012), Sofou et al. (2015) identified compound heterozygous mutations in the PARS2 gene: a 1-bp duplication (c.1130dupC, NM_152268.3), resulting in a frameshift and premature termination (Lys378fsTer1), and a c.836C-T transition, resulting in a ser279-to-leu substitution (S279L; 612036.0002) at a conserved residue in a postulated functional domain. The mutations, which were found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. The mutations were not present in the dbSNP (build 135) or Exome Sequencing Project databases or in 200 Danish or 249 Swedish control individuals. Western blot analysis of patient fibroblasts did not show decreased levels of prolyl-tRNA synthetase. At 2.5 months of age, the patient had onset of seizures associated with hypsarrhythmia on EEG.</Attribute>
              <Citation>
                <ID Source="PubMed">22237560</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">25629079</ID>
              </Citation>
              <XRef DB="OMIM" ID="618437" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PARS2" />
          </GeneList>
          <Name>PARS2, 1-BP DUP, 1130C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 1130C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612036.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="382049" TraitType="Disease" MappingType="Name" MappingValue="DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75" MappingRef="Preferred">
        <MedGen CUI="C5193099" Name="Developmental and epileptic encephalopathy, 75" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

